However, the marker was used successfully to eliminate ALDHbright cells obtained from various cancer cell lines including head and neck, breast, and pancreatic cancer lines in vitro with ALDH1A1-specific CD8+ T cells. The gene discussed is CD8A; the disease is cancer.